Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Quanterix Corp (QTRX)
Sector: Healthcare; Industry: Medical Devices

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-03-23 Duffy David C. SVP R&D and CTO Sell 3,266 $30.00 $97,980 No
2022-02-04 Duffy David C. SVP R&D and CTO Sell 3,266 $30.91 $100,952 No
2022-01-31 Duffy David C. SVP R&D and CTO Sell 3,266 $30.00 $97,980 No
2021-12-29 Duffy David C. SVP R&D and CTO Sell 1,667 $40.71 $67,864 No
2021-11-19 Duffy David C. SVP R&D and CTO Sell 1,667 $45.54 $75,915 No
2021-10-15 Duffy David C. SVP R&D and CTO Sell 1,667 $51.47 $85,800 No
2021-06-23 Duffy David C. SVP R&D and CTO Sell 1,667 $62.11 $103,537 No
2021-05-28 Duffy David C. SVP R&D and CTO Sell 1,667 $51.00 $85,017 No
2021-03-19 Duffy David C. SVP R&D and CTO Sell 1,667 $58.36 $97,286 No
2021-02-11 Duffy David C. SVP R&D and CTO Sell 1,667 $79.62 $132,727 No
2021-01-22 Duffy David C. SVP R&D and CTO Sell 1,667 $79.29 $132,176 No
2020-12-18 Duffy David C. SVP R&D and CTO Sell 1,667 $43.82 $73,048 Yes
2020-11-12 Duffy David C. SVP R&D and CTO Sell 1,667 $49.39 $82,333 No
2020-10-16 Duffy David C. SVP R&D and CTO Sell 1,667 $43.04 $71,748 No
2020-09-17 Duffy David C. SVP R&D and CTO Sell 1,667 $32.43 $54,061 No
2020-08-19 Duffy David C. SVP R&D and CTO Sell 1,680 $34.92 $58,666 No
2020-07-13 Duffy David C. SVP R&D and CTO Sell 1,667 $27.39 $45,659 No
2020-06-16 Duffy David C. SVP R&D and CTO Sell 1,667 $26.35 $43,925 No
2020-05-08 Duffy David C. SVP R&D and CTO Sell 1,667 $26.52 $44,209 No
2020-04-15 Duffy David C. SVP R&D and CTO Sell 1,667 $20.87 $34,790 No
2020-03-19 Duffy David C. SVP R&D and CTO Sell 1,667 $11.46 $19,104 No
2020-02-11 Duffy David C. SVP R&D and CTO Sell 1,667 $27.88 $46,476 No
2020-01-17 Duffy David C. SVP R&D and CTO Sell 1,941 $23.99 $46,565 Yes
2019-12-16 Duffy David C. SVP R&D and CTO Sell 1,667 $24.15 $40,258 Yes
2019-11-18 Duffy David C. SVP R&D and CTO Sell 1,667 $22.56 $37,615 Yes
2019-10-21 Duffy David C. SVP R&D and CTO Sell 1,667 $20.32 $33,873 Yes
2019-09-16 Duffy David C. SVP R&D and CTO Sell 1,667 $25.68 $42,809 Yes
2019-08-19 Duffy David C. SVP R&D and CTO Sell 1,667 $27.99 $46,667 Yes
2019-07-15 Duffy David C. SVP R&D and CTO Sell 1,667 $29.49 $49,154 Yes
2019-06-17 Duffy David C. SVP R&D and CTO Sell 1,667 $32.74 $54,572 Yes

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.